Drug Trial Radar · NCT00812955
Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides
Last checked: Nov 20, 2026Latest source record: Oct 3, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
474
Actual
Start
Nov 2008
Primary completion
Jun 2009
Study completion Jun 2009
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Dec 22, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to test the effect and safety of three different doses of ABT-143 compared to simvastatin in subjects with elevated levels of low density lipoprotein cholesterol ("bad cholesterol") and triglycerides.
Conditions
- Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
Interventions
ABT-143Drug
Once daily for 8 weeks
simvastatinDrug
Once daily for 8 weeks simvastatin capsules 40 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Percent Change From Baseline to the Final Visit in Low-density Lipoprotein Cholesterol (LDL-C) (Full Analysis Set)Time frame: Baseline to 8 weeks
Locations
129 sites in 1 country. Site status is shown where the registry gives one.
Site Reference ID/Investigator# 12654
Birmingham, Alabama
Site Reference ID/Investigator# 12634
Columbiana, Alabama
Site Reference ID/Investigator# 12559
Huntsville, Alabama
Site Reference ID/Investigator# 12499
Ozark, Alabama
Site Reference ID/Investigator# 12673
Chandler, Arizona
Site Reference ID/Investigator# 17282
Scottsdale, Arizona
Site Reference ID/Investigator# 12657
Little Rock, Arkansas
Site Reference ID/Investigator# 12489
Anaheim, California
Site Reference ID/Investigator# 12495
Carmichael, California
Site Reference ID/Investigator# 12467
Chula Vista, California
Site Reference ID/Investigator# 12498
Long Beach, California
Site Reference ID/Investigator# 12602
Los Angeles, California
Site Reference ID/Investigator# 12510
Norwalk, California
Site Reference ID/Investigator# 12550
Palm Desert, California
Site Reference ID/Investigator# 16503
Roseville, California
Site Reference ID/Investigator# 12678
Sacramento, California
Site Reference ID/Investigator# 14241
Sacramento, California
Site Reference ID/Investigator# 12473
San Diego, California
Site Reference ID/Investigator# 12497
Walnut Creek, California
Site Reference ID/Investigator# 12680
West Hills, California
Site Reference ID/Investigator# 12461
Colorado Springs, Colorado
Site Reference ID/Investigator# 12600
Colorado Springs, Colorado
Site Reference ID/Investigator# 12679
Waterbury, Connecticut
Site Reference ID/Investigator# 12598
Clearwater, Florida
Site Reference ID/Investigator# 15542
Coral Gables, Florida
Site Reference ID/Investigator# 12477
Daytona Beach, Florida
Site Reference ID/Investigator# 12668
Delray Beach, Florida
Site Reference ID/Investigator# 15483
Fort Lauderdale, Florida
Site Reference ID/Investigator# 12645
Fort Myers, Florida
Site Reference ID/Investigator# 12672
Hollywood, Florida
Site Reference ID/Investigator# 17504
Jacksonville, Florida
Site Reference ID/Investigator# 12781
Jacksonville, Florida
Site Reference ID/Investigator# 12665
Jupiter, Florida
Site Reference ID/Investigator# 12682
Longwood, Florida
Site Reference ID/Investigator# 15486
Melbourne, Florida
Site Reference ID/Investigator# 12502
New Port Richey, Florida
Site Reference ID/Investigator# 12647
Ocala, Florida
Site Reference ID/Investigator# 12520
Orlando, Florida
Site Reference ID/Investigator# 12687
Ormond Beach, Florida
Site Reference ID/Investigator# 12583
Sarasota, Florida
Showing 40 of 129 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.